Clinical trial
Study of PEG-Intron for Plexiform Neurofibromas
NCT00396019 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00396019 |
|---|---|
| Title | Study of PEG-Intron for Plexiform Neurofibromas |
| Official title | A Phase II Trial of Peginterferon Alfa-2b (PEG-Intron) for Plexiform Neurofibromas |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Plexiform Neurofibroma |
| Intervention type | Drug |
| Interventions | PEG-Intron |
| Enrollment | 86 |
| Start date | Dec 1, 2006 |
| Primary completion | Apr 1, 2014 |
| Completion | Apr 1, 2014 |
| First posted | Nov 6, 2006 |
| Last update posted | Nov 6, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: